Off-label Risperdal prescriptions - Non FDA Approved Uses for Risperdal

Off-label Risperdal prescriptions - Non FDA Approved Uses for Risperdal

Risperdal is a popular treatment for bipolar disorders, autism, and senile dementia, although these are what medical professionals call “off-label” prescriptions. Although these conditions were not tested during the final phases of Risperdal studies, they respond well to the drug despite the lack of information of any potential dangers to prospective patients.

Off-label prescriptions can have deadly consequences. Risperdal is alleged to have caused 37 instances of strokes or stroke-like events in elderly patients undergoing treatment for senior dementia. Unfortunately, 16 people allegedly died as a result of this practice of using Risperdal for off-label uses.

Janssen Pharmecutica and their parent company Johnson & Johnson did not initially discourage off-label prescriptions, for this type of action would reduce the sales and visibility of Risperdal. Another disturbing instance of medical irresponsibility was the fact that Janssen released a letter to Canadian doctors warning of the potentially fatal side effects of Risperdal use in elderly patients a full year before notifying doctors in the U.S. of the same problem.

This example of blatant corporate irresponsibility should not go unpunished. If you or someone you love is a victim of these off-label Risperdal prescriptions, you may have a right to seek financial compensation depending on your situation. Let our lawyers investigate your case and discover if irresponsible pharmaceutical companies should be held accountable for your suffering. Contact an experienced Risperdal attorney today.

[an error occurred while processing this directive]
  • - -
  • By clicking the "Submit" button below, you agree that law firms you are matched with may contact you by telephone even if you are on a federal or state Do Not Call registry. Up to 10 law firms may respond to your request within approximately 2 weeks. In some cases 3 or more firms may respond to your request after 30 days. Use of this site is subject to our Terms of Use.

Home | Sitemap

Website Design & Web Positioning by Wise Law Group

Copyright ©2012- All rights reserved | Terms of Use

Off-label prescriptions can have deadly consequences. Risperdal is alleged to have caused 37 instances of strokes or stroke-like events in elderly patients undergoing treatment for senior dementia.